CrowdStrike Analysts Increase Their Forecasts After Upbeat Earnings

CrowdStrike Holdings Inc (NASDAQ: CRWD) posted better-than-expected earnings for its third quarter.

CrowdStrike Holdings Inc (NASDAQ:CRWD) posted better-than-expected earnings for its third quarter.

CrowdStrike said third-quarter revenue increased 35% year-over-year to $786 million, which beat the consensus estimate of $777.13 million, according to Benzinga Pro. The cybersecurity company reported quarterly earnings of 82 cents per share, which beat analyst estimates of 74 cents per share.

The company anticipates fourth-quarter earnings of 81 cents to 82 cents per share versus estimates of 78 cents per share. It sees full-year earnings in the range of $2.95 to $2.96 per share versus estimates of $2.83 per share.

CrowdStrike shares gained 2.1% to $216.80 in pre-market trading.

These analysts made changes to their price targets on CrowdStrike following earnings announcement.

  • Keybanc increased the price target on CrowdStrike from $240 to $245. Keybanc analyst Eric Heath maintained an Overweight rating.
  • Barclays boosted the price target on CrowdStrike from $225 to $240. Barclays analyst Saket Kalia maintained an Overweight rating.
  • Needham raised the price target on CrowdStrike from $245 to $250. Needham analyst Alex Henderson maintained a Buy rating.
  • Rosenblatt increased the price target on CrowdStrike from $200 to $245. Rosenblatt analyst Catharine Trebnick maintained a Buy rating.
  • JP Morgan raised the price target on CrowdStrike from $210 to $230. JP Morgan analyst Brian Essex maintained an Overweight rating.

 

Read This Next: Insiders Buying Retractable Technologies And 3 Other Penny Stocks

Total
0
Shares
Related Posts
Read More

Flora Growth’s Stock Trading Higher On Pricing $3.2M Public Offering Of Common Shares

Flora Growth Corp. announced on Thursday the pricing of its underwritten public offering of 1.7 million common shares for aggregate gross proceeds of roughly $3.23 million. Clifford Starke, the company's CEO, and an existing investor have agreed to purchase, and have been allocated by Aegis Capital Corp., Common Shares in the offering. Flora said it will use the net proceeds from the transaction that is expected to close on or about Monday, April 8 for general corporate and working capital needs. The move came on the heels of the company's latest move to further cement its global footprint via acquisition in Germany.

FLGC